Tatva Chintan Pharma Chem Limited
NSE: TATVA BSE: TATVA
NSE
1,243.20
43.50 (3.63%)
Prev Close
1199.7
Open Price
1202
Volume
92,103
Today Low / High
1195.4 / 1259.9
52 WK Low / High
621 / 1610
Range
1,181 - 1,305
BSE
1,240.05
39.30 (3.27%)
Prev Close
1200.75
Open Price
1200.8
Volume
4,079
Today Low / High
1200.05 / 1259
52 WK Low / High
610 / 1603.6
Range
1,178 - 1,302
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1243.2 (target range: 1,181 - 1,305), reflecting a change of 43.5 (3.62591%). On the BSE, it is listed at 1240.05 (target range: 1,178 - 1,302), showing a change of 39.3 (3.27295%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
19 Feb
1,202.00
3.43%
18 Feb
1,208.40
-0.72%
17 Feb
1,183.00
2.32%
16 Feb
1,204.40
-1.64%
13 Feb
1,178.00
1.63%
12 Feb
1,185.70
-0.15%
11 Feb
1,197.00
-1.18%
10 Feb
1,227.10
-2.59%
09 Feb
1,161.20
5.99%
06 Feb
1,173.00
-2.47%
05 Feb
1,205.00
-2.10%
04 Feb
1,250.00
-2.78%
03 Feb
1,170.00
6.89%
02 Feb
1,090.20
5.17%
01 Feb
1,151.10
-5.29%
30 Jan
1,116.00
3.42%
29 Jan
1,167.00
-4.94%
28 Jan
1,127.00
3.63%
27 Jan
1,155.00
-3.15%
23 Jan
1,294.00
-10.62%
22 Jan
1,434.20
-11.23%
Tatva Chintan Pharma Chem Limited Graph
Tatva Chintan Pharma Chem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Tatva Chintan Pharma Chem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,243.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,240.05 | 1,252.45 | 1,127.21 - 1,377.70 |
| 1,264.85 | 1,011.88 - 1,517.82 | ||
| 1,277.25 | 894.08 - 1,660.43 | ||
| Bearish Scenario | 1,240.05 | 1,227.65 | 1,104.88 - 1,350.41 |
| 1,215.25 | 972.20 - 1,458.30 | ||
| 1,202.85 | 841.99 - 1,563.70 |
Overview of Tatva Chintan Pharma Chem Limited
ISIN
INE0GK401011
Industry
Chemicals - Specialty
Vol.Avg
98,673
Market Cap
29,081,002,776
Last Dividend
1
Official Website
IPO Date
2021-07-29
DCF Diff
2,115.75
DCF
-970
Financial Ratios Every Investor Needs
Stock Dividend of TATVA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-12 | September 12, 25 | 1 | 1 | 2025-09-12 | 2025-10-03 | |
| 2024-09-06 | September 06, 24 | 2 | 2 | 2024-09-06 | 2024-10-20 | |
| 2023-09-08 | September 08, 23 | 2 | 2 | 2023-09-08 | 2023-10-22 | |
| 2022-09-08 | September 08, 22 | 2 | 2 | 2022-09-09 | 2022-10-22 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 382.71 Cr | 198.94 Cr | 183.77 Cr | 0.4802 | 8.39 Cr | 0.00 Cr | 9.06 Cr | 5.71 Cr | 2.44 | 34.21 Cr | 0.0149 |
| 2024-03-31 | 393.50 Cr | 183.00 Cr | 210.50 Cr | 0.5349 | 7.94 Cr | 5.89 Cr | 146.26 Cr | 30.35 Cr | 13.26 | 68.93 Cr | 0.0771 |
| 2023-03-31 | 423.61 Cr | 232.66 Cr | 190.95 Cr | 0.4508 | 6.04 Cr | 5.07 Cr | 141.82 Cr | 45.49 Cr | 20.52 | 67.63 Cr | 0.1074 |
| 2022-03-31 | 433.65 Cr | 201.50 Cr | 232.15 Cr | 0.5353 | 3.71 Cr | 4.38 Cr | 196.48 Cr | 95.87 Cr | 44.59 | 108.33 Cr | 0.2211 |
| 2021-03-31 | 300.36 Cr | 157.38 Cr | 142.98 Cr | 0.4760 | 2.40 Cr | 2.29 Cr | 115.33 Cr | 52.26 Cr | 26.02 | 66.64 Cr | 0.1740 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11.37 Cr | 836.25 Cr | 97.43 Cr | 738.8240 Cr | 36.39 Cr | 22.29 Cr | 133.95 Cr | 547.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 96.0270 Cr |
| 2024-03-31 | 35.30 Cr | 818.72 Cr | 81.64 Cr | 737.0820 Cr | 14.27 Cr | -21.03 Cr | 152.77 Cr | 499.46 Cr | 3.84 Cr | -27.14 Cr | 3.95 Cr | 79.6630 Cr |
| 2023-03-31 | 27.37 Cr | 756.30 Cr | 241.51 Cr | 514.7910 Cr | 170.26 Cr | 142.89 Cr | 162.50 Cr | 426.52 Cr | 4.10 Cr | -7.29 Cr | -17.80 Cr | 238.6910 Cr |
| 2022-03-31 | 63.02 Cr | 658.30 Cr | 185.21 Cr | 473.0890 Cr | 119.94 Cr | 56.92 Cr | 169.96 Cr | 210.79 Cr | 2.11 Cr | 0.02 Cr | -108.44 Cr | 171.4330 Cr |
| 2021-03-31 | 4.48 Cr | 314.80 Cr | 148.84 Cr | 165.9640 Cr | 90.25 Cr | 85.77 Cr | 72.02 Cr | 130.16 Cr | 0.65 Cr | 0.02 Cr | 0.00 Cr | 118.0150 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 24.6710 Cr | -65.2540 Cr | 16.5660 Cr | -51.6010 Cr | -23.9300 Cr | 11.3740 Cr | -76.2720 Cr | 5.7130 Cr | 22.5340 Cr | -4.6780 Cr | 18.8110 Cr |
| 2024-03-31 | 98.0440 Cr | -120.5400 Cr | 30.5190 Cr | -30.4710 Cr | 7.9390 Cr | 35.3040 Cr | -128.5150 Cr | 30.3540 Cr | -154.7980 Cr | -4.6780 Cr | 9.7320 Cr |
| 2023-03-31 | 27.7830 Cr | -101.1430 Cr | 37.7950 Cr | -175.3270 Cr | -35.6510 Cr | 27.3660 Cr | -203.1100 Cr | 44.7790 Cr | 50.6320 Cr | -4.4330 Cr | 7.4590 Cr |
| 2022-03-31 | 20.3780 Cr | -196.8060 Cr | 234.9640 Cr | -68.7790 Cr | 58.5360 Cr | 63.0170 Cr | -89.1570 Cr | 104.1210 Cr | 28.8590 Cr | 0.0000 Cr | -97.9390 Cr |
| 2021-03-31 | 19.6940 Cr | -20.7020 Cr | -4.4800 Cr | 3.3490 Cr | -5.4880 Cr | 5.3410 Cr | -20.9700 Cr | 60.6960 Cr | -0.4630 Cr | -4.0180 Cr | -8.4630 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 131.33 Cr | 81.04 Cr | 50.30 Cr | 0.3830 | 16.42 Cr | 15.17 Cr | 6.49 | 27.22 Cr | 0.1155 |
| 2025-09-30 | 123.52 Cr | 54.86 Cr | 68.65 Cr | 0.5558 | 13.16 Cr | 9.92 Cr | 4.24 | 23.22 Cr | 0.0803 |
| 2025-06-30 | 116.86 Cr | 58.35 Cr | 58.52 Cr | 0.5007 | 8.36 Cr | 6.65 Cr | 2.84 | 18.49 Cr | 0.0569 |
| 2025-03-31 | 107.86 Cr | 57.69 Cr | 50.18 Cr | 0.4652 | 36.13 Cr | 1.03 Cr | 0.44 | 8.61 Cr | 0.0095 |
| 2024-12-31 | 85.90 Cr | 41.54 Cr | 44.36 Cr | 0.5164 | 31.13 Cr | 0.14 Cr | 0.06 | 6.42 Cr | 0.0016 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 12.54 Cr | 5.31 Cr | 17.85 Cr | 101.62 Cr | 146.04 Cr | 296.44 Cr | 588.89 Cr | 907.74 Cr | 153.35 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 14.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -738.82 Cr |
| 2025-03-31 | 14.10 Cr | 0.00 Cr | 14.10 Cr | 82.76 Cr | 133.95 Cr | 265.25 Cr | 547.09 Cr | 836.25 Cr | 97.43 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 14.87 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -737.60 Cr |
| 2024-09-30 | 12.22 Cr | 3.23 Cr | 15.44 Cr | 66.40 Cr | 144.48 Cr | 250.09 Cr | 534.46 Cr | 807.02 Cr | 69.42 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 6.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 1.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 5.21 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Chemicals - Specialty
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Asian Paints Limited | ASIANPAINT | ₹2,400.80 | ₹2,301,393,217,047.00 | ₹971,467.00 |
| Pidilite Industries Limited | PIDILITIND | ₹1,464.90 | ₹1,490,849,285,477.00 | ₹407,249.00 |
| Solar Industries India Limited | SOLARINDS | ₹13,370.00 | ₹1,209,852,035,350.00 | ₹102,727.00 |
| SRF Limited | SRF | ₹2,678.70 | ₹794,033,178,728.00 | ₹550,333.00 |
| Linde India Limited | LINDEINDIA | ₹6,789.50 | ₹579,037,232,059.00 | ₹55,355.00 |
| Berger Paints India Limited | BERGEPAINT | ₹457.45 | ₹533,371,261,063.00 | ₹163,781.00 |
| Himadri Speciality Chemical Limited | HSCL | ₹473.20 | ₹238,727,034,000.00 | ₹3,909,439.00 |
| Atul Ltd | ATUL | ₹6,600.00 | ₹194,315,583,000.00 | ₹17,422.00 |
| Acutaas Chemicals Ltd. | ACUTAAS | ₹2,102.40 | ₹172,125,846,893.00 | ₹315,580.00 |
| DCM Shriram Limited | DCMSHRIRAM | ₹1,082.10 | ₹168,744,838,200.00 | ₹18,307.00 |
| Aarti Industries Limited | AARTIIND | ₹454.45 | ₹164,780,843,300.00 | ₹620,980.00 |
| Kansai Nerolac Paints Limited | KANSAINER | ₹200.50 | ₹162,109,209,368.00 | ₹3,372,812.00 |
| Vinati Organics Limited | VINATIORGA | ₹1,482.60 | ₹153,694,666,003.00 | ₹12,365.00 |
| BASF India Limited | BASF | ₹3,550.50 | ₹153,685,664,820.00 | ₹25,976.00 |
| Anupam Rasayan India Limited | ANURAS | ₹1,337.80 | ₹152,305,854,400.00 | ₹282,130.00 |
| Akzo Nobel India Limited | AKZOINDIA | ₹3,040.20 | ₹138,451,662,623.00 | ₹16,275.00 |
| Fine Organic Industries Limited | FINEORG | ₹4,494.90 | ₹137,813,526,122.00 | ₹8,637.00 |
| Aether Industries Limited | AETHER | ₹960.10 | ₹127,364,302,533.00 | ₹79,205.00 |
| PCBL Limited | PCBL | ₹306.65 | ₹120,655,307,517.00 | ₹808,702.00 |
| Privi Speciality Chemicals Limited | PRIVISCL | ₹2,883.50 | ₹112,637,312,751.00 | ₹92,167.00 |
| Garware Hi-Tech Films Limited | GRWRHITECH | ₹4,202.20 | ₹97,627,166,067.00 | ₹38,816.00 |
| Ami Organics Limited | AMIORG | ₹1,176.30 | ₹96,302,382,365.00 | ₹242,994.00 |
| Clean Science and Technology Limited | CLEAN | ₹736.90 | ₹78,314,784,400.00 | ₹162,839.00 |
| Alkyl Amines Chemicals Limited | ALKYLAMINE | ₹1,520.50 | ₹77,764,526,505.00 | ₹17,871.00 |
| Sudarshan Chemical Industries Limited | SUDARSCHEM | ₹923.80 | ₹72,621,673,220.00 | ₹34,274.00 |
| Galaxy Surfactants Limited | GALAXYSURF | ₹1,910.80 | ₹67,746,940,122.00 | ₹17,217.00 |
| Kingfa Science & Technology (India) Limited | KINGFA | ₹4,089.60 | ₹55,419,727,738.00 | ₹2,603.00 |
| Gulf Oil Lubricants India Limited | GULFOILLUB | ₹1,094.80 | ₹54,083,201,015.00 | ₹54,331.00 |
| Responsive Industries Limited | RESPONIND | ₹183.56 | ₹48,938,664,337.00 | ₹130,142.00 |
| Indigo Paints Limited | INDIGOPNTS | ₹965.50 | ₹46,030,851,661.00 | ₹65,042.00 |
| Laxmi Organic Industries Limited | LXCHEM | ₹141.48 | ₹39,210,881,072.00 | ₹765,075.00 |
| Pondy Oxides And Chemicals Limited | POCL | ₹1,186.60 | ₹36,204,683,661.00 | ₹121,345.00 |
| Balaji Amines Limited | BALAMINES | ₹1,100.60 | ₹35,660,540,600.00 | ₹101,559.00 |
| Neogen Chemicals Limited | NEOGEN | ₹1,345.30 | ₹35,491,266,032.00 | ₹43,876.00 |
| Vishnu Chemicals Limited | VISHNU | ₹510.15 | ₹34,340,892,133.00 | ₹50,916.00 |
| Advanced Enzyme Technologies Limited | ADVENZYMES | ₹304.65 | ₹34,098,499,620.00 | ₹188,766.00 |
| Tatva Chintan Pharma Chem Limited | TATVA | ₹1,243.20 | ₹29,081,002,776.00 | ₹92,103.00 |
| Grauer & Weil (India) Limited | GRAUWEIL | ₹117.90 | ₹29,075,437,490.00 | ₹464,402.00 |
| Prince Pipes and Fittings Limited | PRINCEPIPE | ₹261.57 | ₹28,919,461,434.00 | ₹85,080.00 |
| Ddev Plastiks Industries Ltd. | DDEVPLSTIK | ₹276.70 | ₹28,631,992,929.00 | ₹48,929.00 |
| Rossari Biotech Limited | ROSSARI | ₹511.30 | ₹28,317,515,036.00 | ₹44,930.00 |
| Jubilant Agri and Consumer Products Ltd. | JUBLCPL | ₹1,858.10 | ₹28,154,847,243.00 | ₹2,873.00 |
Key Executives
Whole Time Director
Ajaykumar Mansukhlal Patel
Gender: male
Year Born: 1972
Whole Time Director
Shekhar Rasiklal Somani
Gender: male
Year Born: 1974
Assistant Vice President of Research and Development
Ajay Rawat
Gender: male
Year Born:
Chief Financial Officer
Ajesh Kumar Mohanan Pillai
Gender: male
Year Born:
Chairman & MD
Chintan Nitinkumar Shah
Gender: male
Year Born: 1973
Head of Operations
Harish Laljibhai Patel
Gender: male
Year Born:
Company Secretary & Compliance Officer
Ishwar Nayi
Gender: male
Year Born:
Deputy General Manager of Commercial
Rakeshkumar P Poonia
Gender: male
Year Born:
FAQs about Tatva Chintan Pharma Chem Limited
Who is the CEO of the company?
The CEO is Chintan Nitinkumar Shah.
What is the current market price of the stock?
The current price is ₹1,243.20.
What is the 52-week price range?
The range is ₹621-1610.
What is the market capitalization of the company?
The market capitalization is ₹2,908.10 crores.
What is the dividend yield?
The dividend yield is 0.08%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 88.67.
Which sector does the company belong to?
The company operates in the Basic Materials sector.
What does the company do?
Overview of Tatva Chintan Pharma Chem Limited (ISIN: INE0GK401011) is a leading Chemicals - Specialty in India. With a market capitalization of ₹2,908.10 crores and an average daily volume of 98,673 shares, it operates in the Chemicals - Specialty. The company last declared a dividend of ₹1.